The observational study of the safety assesment during the periendoscopic period in antithrombotic drug-users

The observational study of the safety assesment during the periendoscopic period in antithrombotic drug-users - O-GUTS clinical study of antithrombotic drugs

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012066

Enrollment

2000

Registered

2013-10-18

Start date

2013-10-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The case of endoscopic forceps biopsy or endoscopic treatment in patients taking antithrombotic drugs

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who were given a written informed consent 2)Patients who take antithrombotic drugs and need endoscopic forceps biopsy or endoscopic treatment

Exclusion criteria

Exclusion criteria: Patients who were disqualified for the study by their physiciens

Design outcomes

Primary

Measure	Time frame
The incidence of bleeding after endoscopic forceps biopsy or endoscopic treatment	—

Secondary

Measure	Time frame
1)The incidence of thromboembolic events 2)The incidence of complications except for bleeding	—

Countries

Japan

Contacts

Public ContactYoshiyasu Kono, Minoru Matsubara

Okayama University Hospital Department of Gastroenterology

hxnwq178@yahoo.co.jp086-235-7219

Outcome results